Literature DB >> 31055075

Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.

Shinya Katsumata1, Keiju Aokage2, Genichiro Ishii3, Shoko Nakasone1, Takashi Sakai1, Satoshi Okada1, Tomohiro Miyoshi1, Kenta Tane1, Masahiro Tsuboi1.   

Abstract

INTRODUCTION: Current nodal staging of NSCLC is defined only by anatomical location of lymph nodes (LNs). The aim of this study is to investigate prognostic impacts of the number of metastatic LNs by stratifying the present N classification.
METHODS: We analyzed 1989 patients with NSCLC who underwent complete resection by lobectomy or pneumonectomy involving dissection of the hilar and mediastinal LNs from 2003 to 2012. We classified patients according to the number of metastatic nodes and stations and their current category of metastatic LNs. We analyzed the overall survival in each group and assessed the survival impact of the combination of them.
RESULTS: In the multivariate analyses of all patients, pathological N1 (pN1) (reference [ref.] pN2) and single-node metastasis (ref. multiple-node) were independent prognostic factors whereas single-station metastasis (ref. multiple-station) was not. In the respective multivariate analyses of pN1 and pN2 disease, multiple-node metastasis (ref. single-node) was an independent prognostic factor in pN1 disease (hazard ratio: 1.41, p = 0.04), but not in pN2 disease. Investigation for other boundaries of a number of metastatic LNs of three or more (ref. one to two), four or more (ref. one to three), and five or more (ref. one to four) found that all of them were independent prognostic factors in both pN1 and pN2 diseases.
CONCLUSIONS: The number of metastatic LNs had a strong impact on survival in addition to the current pN classification. To clarify its prognostic impact, further study is needed in other datasets including patients treated by nonsurgical modalities.
Copyright © 2019 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lymph node metastasis; NSCLC; Number of metastatic lymph nodes; Number of metastatic station; TNM

Mesh:

Year:  2019        PMID: 31055075     DOI: 10.1016/j.jtho.2019.04.016

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  13 in total

1.  Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma.

Authors:  Kotaro Nomura; Keiju Aokage; Tokiko Nakai; Shingo Sakashita; Tomohiro Miyoshi; Kenta Tane; Joji Samejima; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

2.  Consistency and prognostic value of preoperative staging and postoperative pathological staging using 18F-FDG PET/MRI in patients with non-small cell lung cancer.

Authors:  Akiko Kajiyama; Kimiteru Ito; Hirokazu Watanabe; Sunao Mizumura; Shun-Ichi Watanabe; Yasushi Yatabe; Tatsuya Gomi; Masahiko Kusumoto
Journal:  Ann Nucl Med       Date:  2022-10-20       Impact factor: 2.258

3.  Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancer.

Authors:  Joji Samejima; Hiroyuki Ito; Takuya Nagashima; Daiji Nemoto; Daisuke Eriguchi; Haruhiko Nakayama; Norihiko Ikeda; Morihito Okada
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

4.  Development and Validation of a Combined Model for Preoperative Prediction of Lymph Node Metastasis in Peripheral Lung Adenocarcinoma.

Authors:  Qi Li; Xiao-Qun He; Xiao Fan; Chao-Nan Zhu; Jun-Wei Lv; Tian-You Luo
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

5.  New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.

Authors:  Jiaqi Zhang; Lei Liu; Guige Wang; Cheng Huang; Yeye Chen; Ye Zhang; Chao Guo; Shanqing Li
Journal:  Thorac Cancer       Date:  2019-10-16       Impact factor: 3.500

6.  The Prognostic Value Of Lymph Node Ratio In Patients With N2 Stage Lung Squamous Cell Carcinoma: A Nomogram And Heat Map Approach.

Authors:  Guoshu Bi; Tao Lu; Guangyu Yao; Yunyi Bian; Mengnan Zhao; Yiwei Huang; Yi Zhang; Liang Xue; Cheng Zhan; Hong Fan
Journal:  Cancer Manag Res       Date:  2019-11-06       Impact factor: 3.989

7.  Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy.

Authors:  Chenlu Li; Jingjing Pan; Jing Luo; Xupeng Chen
Journal:  BMC Pulm Med       Date:  2021-11-29       Impact factor: 3.317

8.  Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis.

Authors:  Qiu Dong; Jialin Deng; Tsz Ngai Mok; Junyuan Chen; Zhengang Zha
Journal:  Int J Gen Med       Date:  2021-12-02

9.  Survival Rates of Patients with Non-Small Cell Lung Cancer Depending on Lymph Node Metastasis: A Focus on Saliva.

Authors:  Lyudmila V Bel'skaya; Elena A Sarf; Victor K Kosenok
Journal:  Diagnostics (Basel)       Date:  2021-05-20

10.  Survival Analysis in Single N2 Station Lung Adenocarcinoma: The Prognostic Role of Involved Lymph Nodes and Adjuvant Therapy.

Authors:  Marco Chiappetta; Filippo Lococo; Giovanni Leuzzi; Isabella Sperduti; Emilio Bria; Leonardo Petracca Ciavarella; Felice Mucilli; Pier Luigi Filosso; Giovannibattista Ratto; Lorenzo Spaggiari; Francesco Facciolo; Stefano Margaritora
Journal:  Cancers (Basel)       Date:  2021-03-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.